Search for: "APP Pharmaceuticals, Inc." Results 141 - 160 of 417
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
26 Sep 2011, 12:30 pm by FDABlog HPM
Court of Appeals for the Federal Circuit (where APP Pharmaceuticals, LLC (“APP”) has been duking it out with MDCO – see here and here) given all of the twists and turns that have occurred with the ANGIOMAX ‘404 patent PTE over the years. [read post]
8 Sep 2011, 12:00 pm by Bexis
Ortho-McNeil Pharmaceutical, Inc., 2011 WL 3566855 (N.D. [read post]
24 Jul 2014, 12:54 pm
District Judge Tanya Walton Pratt concluded that Defendants Teva Parenteral Medicines, Inc. of Irvine, California; APP Pharmaceuticals, LLC of Schaumburg, Illinois; Pliva Hrvatska D.O.O. of Zagreb, Croatia; Teva Pharmaceuticals USA Inc. of North Wales, Pennsylvania; and Barr Laboratories, Inc. of Montvale, New Jersey failed to prove invalidity of U.S. [read post]
27 Dec 2012, 5:07 am by Erin Kristofco
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579, 593-94 (1993) are relevant to the Court’s reliability determination under CRE 702, which is identical to FRE 702. [read post]
21 May 2014, 7:20 am by Joe Consumer
”) If you’ve got an itchy ear, don’t put drops manufactured by Cincinnati-based Masters Pharmaceuticals Inc. in it! [read post]
13 Jun 2011, 5:32 pm by FDABlog HPM
  Several other generic drug manufacturers submitted ANDAs to FDA containing Paragraph IV certifications to Orange Book-listed patents on GEMZAR, including APP Pharmaceuticals, Inc. [read post]
8 May 2008, 12:22 pm
Wyeth Pharmaceuticals, 2008 WL 1821379 (5th Cir. [read post]
22 Nov 2009, 11:25 pm
Makers of the anesthetics used in pain pumps, such as APP Pharmaceuticals Inc. and Hospira Inc., will also have to update their labels. [read post]